drugset / Trial / NCT03414723
A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril
NaSingle-groupOpen-labelBasic science
Summary
Primary Objective: To evaluate the effects of multiple-dose ramipril on the steady state pharmacokinetic (PK) parameters of sotagliflozin and its main metabolite (sotagliflozin-3-O-glucuronide) in healthy male and female subjects. Secondary Objectives: * To assess the effects of multiple-dose sotagliflozin on the PK of ramipril and its active metabolite (ramiprilat). * To assess the safety and tolerability of multiple-dose sotagliflozin with and without multiple-dose of ramipril.
Timeline
- Start
- 2018-01-15
- Primary completion
- 2018-03-10
- Completion
- 2018-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramipril | Small molecule | — | Oral |
| Subject | Sotagliflozin | Small molecule | — | Oral |